Immunogenicity and Adverse Events after Coronavirus Disease 2019 (COVID-19) Vaccination in Patients with Systemic Inflammatory Autoimmune Diseases

COVID-19 Vaccines in a Cohort of Egyptian Patients with Auto-Immune Rheumatic Diseases

Flaring of Arthritis in Rheumatoid Arthritis patients after COVID-19 Vaccination

Pneumonia in Rheumatoid Arthritis Patients

COVID-19 VACCINE IN EGYPTIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, RHEUMATOID ARTHRITIS AND OTHER RHEUMATIC DISEASES

Clinical Impact of COVID-19 Infection on Rheumatoid Arthritis Patients

New 2015 American College of Rheumatology (ACR) Rheumatoid Arthritis Guidelines

COVID-19 among Rheumatoid Arthritis Patients on ‎Immunosuppressive Therapy During the First Wave of the COVID-‎‎19 Pandemic: a Prospective Comparative Study ‎

ROLE OF ANTI-INFLAMMATORY AND IMMUNOMODULATORY AGENTS IN RHEUMATOID ARTHRITIS.

Role of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients during COVID-19 Pandemic